These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11342095)

  • 21. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proximal deep vein thrombosis after hip replacement for oncologic indications.
    Nathan SS; Simmons KA; Lin PP; Hann LE; Morris CD; Athanasian EA; Boland PJ; Healey JH
    J Bone Joint Surg Am; 2006 May; 88(5):1066-70. PubMed ID: 16651581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
    Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
    Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty].
    Yang Z; Liu X; Dai S; Liu K; Zhang Y; Sun J; Yin X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Sep; 24(9):1058-61. PubMed ID: 20939473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolic prophylaxis after elective total hip arthroplasty.
    Conduah A; Lieberman JR
    Clin Orthop Relat Res; 2005 Dec; 441():274-84. PubMed ID: 16331015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
    Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An equivalence study of two low-molecular-weight heparins in the prevention and treatment of deep-vein thrombosis after total hip replacement.
    Planès A
    Semin Thromb Hemost; 2000; 26 Suppl 1():57-60. PubMed ID: 11011808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with ximelagatran in orthopaedic surgery.
    Eriksson B
    Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current recommendations for extended out-of-hospital thromboprophylaxis following total hip arthroplasty.
    Krotenberg R
    Am J Orthop (Belle Mead NJ); 2004 Apr; 33(4):180-4. PubMed ID: 15132325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials.
    Rausa E; Kelly ME; Asti E; Aiolfi A; Bonitta G; Winter DC; Bonavina L
    Surgery; 2018 Dec; 164(6):1234-1240. PubMed ID: 30190110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
    Li XL; Lu WJ; Yu NS
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
    J Bone Joint Surg Am; 1994 Aug; 76(8):1174-85. PubMed ID: 8056798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.
    Lassen MR; Borris LC; Anderson BS; Jensen HP; Skejø Bro HP; Andersen G; Petersen AO; Siem P; Hørlyck E; Jensen BV; Thomsen PB; Hansen BR; Erin-Madsen J; Møller JC; Rotwitt L; Christensen F; Nielsen JB; Jørgensen PS; Paaske B; Tørholm C; Hvidt P; Jensen NK; Nielsen AB; Appelquist E; Tjalve E
    Thromb Res; 1998 Mar; 89(6):281-7. PubMed ID: 9669750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal low-molecular-weight heparin regimen in major orthopaedic surgery. A meta-analysis of randomised trials.
    Zufferey P; Laporte S; Quenet S; Molliex S; Auboyer C; Decousus H; Mismetti P
    Thromb Haemost; 2003 Oct; 90(4):654-61. PubMed ID: 14515186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between peri-operative antithrombin activity and deep vein thrombosis after elective hip replacement surgery.
    Urbach D; Matzen KA; Heitmann D; Neumann HW
    Vasa; 2003 Feb; 32(1):14-7. PubMed ID: 12677759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.